Water contamination collaboration
Agilent Technologies will collaborate with Dr Shane Snyder ? an internationally recognized authority on water contamination from the University of Arizona?s Department of Chemical and Environmental Engineering ? and the university?s BIO5 Institute to develop new methods of detecting emerging contaminants in water, according to a company press release.
Agilent Technologies will collaborate with Dr Shane Snyder — an internationally recognized authority on water contamination from the University of Arizona’s Department of Chemical and Environmental Engineering — and the university’s BIO5 Institute to develop new methods of detecting emerging contaminants in water, according to a company press release.
Emerging contaminants can include pharmaceuticals, personal care products and other commonly used substances. The collaboration aims to increase the ability to accurately detect contamination in water supplies.
Dr Snyder commented that the partnership with Agilent will allow the University of Arizona to more effectively influence water reuse and desalination strategies by ensuring that the required water quality has been achieved for its intended use.
“Not only will we investigate known potential threats to water quality, we will also bridge the gap between detection and health by developing methodologies that can screen water for toxicity from multiple compounds,” he said.
The concept of addressing contaminants in potable water as mixtures — instead of separate chemicals— is of great interest to the regulatory, scientific and public communities.
The collaboration will be centered at the BIO5 Institute on the University of Arizona campus, where the infrastructure for cross-disciplinary work combining biological and chemical research already exists.
The BIO5 Institute at the University of Arizona mobilizes top researchers in five disciplines — agriculture, engineering, medicine, pharmacy and basic science — to find solutions to important health and environmental problems.
For more information, visit www.engineering.arizona.edu, www.bio5.org or www.agilent.com
This story originally appeared in The Column. Click here to view that issue.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
